Robert A. Bradway
Chairman, CEO and President at Amgen Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: The Boeing Company, 3 years.
The Boeing Company
Director
Amgen Inc.
Director · Chairman, CEO and President
Chief executive roles
Amgen Inc.
· Chairman, CEO and President
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 2, 2024 | Amgen Inc. | Gift | −96,000 | — | — |
| Dec 2, 2024 | Amgen Inc. | Gift | +90,000 | — | — |
| Dec 2, 2024 | Amgen Inc. | Gift | −90,000 | — | — |
| May 7, 2024 | Amgen Inc. | Grant or award | +11,988 | — | — |
| May 5, 2024 | Amgen Inc. | Shares withheld for tax | −2,220 | $311.29 | $691,064 |
| May 2, 2024 | Amgen Inc. | Shares withheld for tax | −2,294 | $277.37 | $636,287 |
| Apr 30, 2024 | Amgen Inc. | Shares withheld for tax | −2,282 | $276.38 | $630,699 |
| Mar 18, 2024 | Amgen Inc. | Shares withheld for tax | −20,560 | $268.87 | $5,527,967 |
| Mar 6, 2024 | Amgen Inc. | Grant or award | +41,133 | — | — |
| May 5, 2023 | Amgen Inc. | Shares withheld for tax | −2,083 | $231.89 | $483,027 |
| May 3, 2023 | Amgen Inc. | Shares withheld for tax | −2,863 | $235.97 | $675,582 |
| May 2, 2023 | Amgen Inc. | Grant or award | +13,486 | — | — |
| Apr 30, 2023 | Amgen Inc. | Shares withheld for tax | −2,208 | $239.74 | $529,346 |
| Mar 17, 2023 | Amgen Inc. | Shares withheld for tax | −13,971 | $234.57 | $3,277,177 |
| Mar 6, 2023 | Amgen Inc. | Grant or award | +27,915 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.